Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
In both studies, EGRIFTA-treated patients completing the 26-week treatment period were re-randomized to blinded therapy with either daily placebo or a 2 mg dose of EGRIFTA (1 mg/vial formulation) for an additional 26-week treatment period (Extension Phase) in order to assess maintenance of VAT reduction and to gather long-term safety data
You might end up going on HRT
Reasonable candidates are patients already engaged in a supervised weight-loss programme with diet and activity in place, who understand it is adjunctive
Our BPC-157 is manufactured in China in GMP-compliant facilities with high-purity (99%) pharmaceutical-grade quality , supplied as a stable lyophilized powder for flexible formulation work in the lab
Most patients tolerate provider-guided peptide therapy well when used under medical supervision
US$ 20.71
US$ 22.17
US$ 24.38
US$ 27.06
US$ 28.02
US$ 25.18
US$ 28.06